278 related articles for article (PubMed ID: 18410569)
21. Stem cell engineering for the treatment of severe hemoglobinopathies.
Sadelain M; Boulad F; Lisowki L; Moi P; Riviere I
Curr Mol Med; 2008 Nov; 8(7):690-7. PubMed ID: 18991654
[TBL] [Abstract][Full Text] [Related]
22. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.
Sabatino DE; Seidel NE; Aviles-Mendoza GJ; Cline AP; Anderson SM; Gallagher PG; Bodine DM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13294-9. PubMed ID: 11069298
[TBL] [Abstract][Full Text] [Related]
23. Lentivirus vectors in β-thalassemia.
Payen E; Colomb C; Negre O; Beuzard Y; Hehir K; Leboulch P
Methods Enzymol; 2012; 507():109-24. PubMed ID: 22365771
[TBL] [Abstract][Full Text] [Related]
24. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
Fragkos M; Anagnou NP; Tubb J; Emery DW
Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
[TBL] [Abstract][Full Text] [Related]
25. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
Lebensburger J; Persons DA
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
[TBL] [Abstract][Full Text] [Related]
26. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
27. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
Sadelain M
Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
[No Abstract] [Full Text] [Related]
28. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for β-thalassaemia: the continuing challenge.
Yannaki E; Emery DW; Stamatoyannopoulos G
Expert Rev Mol Med; 2010 Oct; 12():e31. PubMed ID: 20883576
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
31. Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
[TBL] [Abstract][Full Text] [Related]
32. Update on gene therapy for hemoglobin disorders.
Persons DA
Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
[TBL] [Abstract][Full Text] [Related]
33. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
35. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A
Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
[TBL] [Abstract][Full Text] [Related]
36. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients.
Persons DA
Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775
[TBL] [Abstract][Full Text] [Related]
37. Genetic strategies for the treatment of sickle cell anaemia.
Mansilla-Soto J; Rivière I; Sadelain M
Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
[TBL] [Abstract][Full Text] [Related]
38. [The possible mechanisms underlying low expression of human beta-globin gene cloned in a retroviral vector].
Dong WJ; Zu ZX; Liu DP; Hao DL; Guo ZC; Liang CC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):763-8. PubMed ID: 12417921
[TBL] [Abstract][Full Text] [Related]
39. Molecular therapies in beta-thalassaemia.
Quek L; Thein SL
Br J Haematol; 2007 Feb; 136(3):353-65. PubMed ID: 17129232
[TBL] [Abstract][Full Text] [Related]
40. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.
Hanawa H; Hargrove PW; Kepes S; Srivastava DK; Nienhuis AW; Persons DA
Blood; 2004 Oct; 104(8):2281-90. PubMed ID: 15198957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
